Table 1 Expression of HER2 and EGFR in primary tumours of CRC patients with ovarian and non-ovarian metastases
Total (n) | Expression (n) | Positive rate (%) | Z | P | |||||
|---|---|---|---|---|---|---|---|---|---|
(−) | (+) | (++) | (+++) | ||||||
HER2 | Ovarian metastasis | 22 | 4 | 6 | 6 | 6 | 54.5 | −2.004 | 0.045 |
Non-ovarian metastasis | 22 | 12 | 2 | 5 | 3 | 36.4 | |||
EGFR | Ovarian metastasis | 22 | 1 | 7 | 6 | 8 | 63.6 | −1.055 | 0.315 |
Non-ovarian metastasis | 24 | 7 | 3 | 7 | 7 | 58.3 | |||